Smith & Nephew tanks 13% after reducing full-year growth guidance
Full-year guidance reducedChina to remain a dragStronger margin gains from 2025Smith & Nephew (SN.) sank to the bottom of the FTSE 100 index, falling 13% to a new six-month low of 956.78p after the knee and hip implants maker lowered full-year revenue growth guidance on China headwinds.The shares are down around 11% for the year, compared with a 5% gain for the blue-chip FTSE 100 index. CEO